Novacyt S.A.
NVYTF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $13,696 | $5,847 | $11,490 | – |
| % Growth | 134.3% | -49.1% | – | – |
| Cost of Goods Sold | $7,793 | $1,962 | $9,480 | – |
| Gross Profit | $5,903 | $3,885 | $2,010 | – |
| % Margin | 43.1% | 66.4% | 17.5% | – |
| R&D Expenses | $2,857 | $1,220 | $1,565 | – |
| G&A Expenses | $4,790 | $4,908 | $0 | – |
| SG&A Expenses | $12,209 | $6,577 | $9,590 | – |
| Sales & Mktg Exp. | $1,629 | $1,669 | $0 | – |
| Other Operating Expenses | $0 | $353 | $0 | – |
| Operating Expenses | $15,067 | $8,150 | $11,155 | – |
| Operating Income | -$4,162 | -$4,265 | -$9,146 | – |
| % Margin | -30.4% | -72.9% | -79.6% | – |
| Other Income/Exp. Net | $68 | $70 | -$17,409 | – |
| Pre-Tax Income | -$4,094 | -$4,195 | -$26,555 | – |
| Tax Expense | -$373 | $159 | -$633 | – |
| Net Income | -$3,695 | -$3,786 | -$29,699 | – |
| % Margin | -27% | -64.8% | -258.5% | – |
| EPS | -0.13 | -0.057 | -0.42 | – |
| % Growth | -127.7% | 86.4% | – | – |
| EPS Diluted | -0.13 | -0.06 | -0.42 | – |
| Weighted Avg Shares Out | 70,626 | 63,420 | 70,626 | – |
| Weighted Avg Shares Out Dil | 70,626 | 70,626 | 70,626 | – |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $265 | – |
| Interest Expense | $450 | $0 | $415 | – |
| Depreciation & Amortization | $1,179 | $1,208 | $4,896 | – |
| EBITDA | -$2,525 | -$2,587 | -$21,244 | – |
| % Margin | -18.4% | -44.2% | -184.9% | – |